Business Description
Arcadia Biosciences Inc
NAICS : 311999
SIC : 2099
ISIN : US0390143032
Total Employee Number:
8Compare
Compare
Traded in other countries / regions
RKDA.USA17D.Germany IPO Date
2015-05-15Description
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 338.18 | |||||
Equity-to-Asset | 0.54 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -78.81 | |||||
Beneish M-Score | -8.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.1 | |||||
3-Year EBITDA Growth Rate | 33.4 | |||||
3-Year EPS without NRI Growth Rate | 42.9 | |||||
3-Year FCF Growth Rate | 47.1 | |||||
3-Year Book Growth Rate | -55.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.48 | |||||
9-Day RSI | 24.55 | |||||
14-Day RSI | 29.11 | |||||
3-1 Month Momentum % | -39.89 | |||||
6-1 Month Momentum % | -64.86 | |||||
12-1 Month Momentum % | -79.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.79 | |||||
Quick Ratio | 3.17 | |||||
Cash Ratio | 2.73 | |||||
Days Inventory | 147.15 | |||||
Days Sales Outstanding | 69.96 | |||||
Days Payable | 187.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.6 | |||||
Shareholder Yield % | -133.94 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.49 | |||||
Operating Margin % | -200.78 | |||||
Net Margin % | -195.94 | |||||
EBITDA Margin % | -200.21 | |||||
FCF Margin % | -89.32 | |||||
OCF Margin % | -89.32 | |||||
ROE % | -179.94 | |||||
ROA % | -113.06 | |||||
ROIC % | -421.28 | |||||
3-Year ROIIC % | -106.47 | |||||
ROC (Joel Greenblatt) % | -1481.54 | |||||
ROCE % | -151.79 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.22 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.5 | |||||
EV-to-EBIT | 0.31 | |||||
EV-to-EBITDA | 0.32 | |||||
EV-to-Revenue | -0.63 | |||||
EV-to-Forward-Revenue | 0.32 | |||||
EV-to-FCF | 0.71 | |||||
Price-to-GF-Value | 0.25 | |||||
Price-to-Median-PS-Value | 0.06 | |||||
| Price-to-Net-Current-Asset-Value | 0.52 | |||||
| Price-to-Net-Cash | 1.12 | |||||
Earnings Yield (Greenblatt) % | 322.58 | |||||
FCF Yield % | -297.2 |
Arcadia Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arcadia Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-18 13:00 | In 173 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 130 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 46 days | ||
| First quarter earnings conference call for 2026 | 2026-05-15 14:00 | 1.07 (+0.94%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 1.07 (+0.94%) | ||
| Annual report for 2025 | 2026-03-26 | 1.70 (-1.79%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 1.70 (-1.79%) | ||
| General meeting for 2025 | 2025-12-19 13:00 | 3.71 (+5.40%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 3.90 (+5.69%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 4.63 (-0.43%) |
Show
Entries
Guru Commentaries on NAS:RKDA
No articles.
Press Release
Articles on Arcadia Biosciences Inc
No articles.
Headlines
See More- 1
Jun 12, 2026
Arcadia Biosciences dips 8% on $4M private placement
Seeking Alpha • 4:57am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers